logo
Plus   Neg
Share
Email

Evotec Forms Breakpoint Therapeutics

Evotec SE (EVTCY.PK) said that it formed Breakpoint Therapeutics GmbH, a spin-off company focusing on the development of Evotec's DNA damage response or "DDR" portfolio.

Breakpoint Therapeutics, which aims to accelerate early projects through discovery and pre-clinical development and expect to deliver the first IND-ready drug in 2022, will initially focus on advancing multiple drug discovery programmes initiated at Evotec that address high unmet medical needs of different patient groups.

The early stage funding amounting to 30 million euros will be covered by a consortium led by Medicxi, Taiho Ventures LLC, and Evotec. Evotec will hold below 50% of the company and consolidate at equity accordingly.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon said that Prime members in select areas can shop a number of items until Christmas Eve and receive them on the same day itself with Prime free same-day delivery and free two-hour delivery. The option is available through Amazon Fresh and Whole Foods Market. In addition to groceries, Prime members in select cities can shop Amazon Fresh for tens of thousands of items. Profile Design recalled about 260 units of Aeria Ultimate carbon aerobars for possible crash hazard, a statement by the U.S. Consumer Product Safety Commission showed. The company said the bicycle aerobars can crack and break, causing the rider to lose control and crash. The recall involves Profile Design Aeria Ultimate carbon aerobars, sold in one size and all matte black in color. Lufthansa Group Airlines (DLAKF, DLAKY) reported Thursday that it served around 10.4 million passengers in November 2019. It represented a decline of 2.3 percent from the previous year, due to declining passenger numbers on flights within Europe. The capacity or available seat kilometres, was also...
Follow RTT
>